145 related articles for article (PubMed ID: 21874357)
1. Rapamycin protects against dominant negative-HNF1A-induced apoptosis in INS-1 cells.
Farrelly AM; Kilbride SM; Bonner C; Prehn JH; Byrne MM
Apoptosis; 2011 Nov; 16(11):1128-37. PubMed ID: 21874357
[TBL] [Abstract][Full Text] [Related]
2. Early loss of mammalian target of rapamycin complex 1 (mTORC1) signalling and reduction in cell size during dominant-negative suppression of hepatic nuclear factor 1-alpha (HNF1A) function in INS-1 insulinoma cells.
Farrelly AM; Wobser H; Bonner C; Anguissola S; Rehm M; Concannon CG; Prehn JH; Byrne MM
Diabetologia; 2009 Jan; 52(1):136-44. PubMed ID: 18949455
[TBL] [Abstract][Full Text] [Related]
3. AMP-activated protein kinase mediates apoptosis in response to bioenergetic stress through activation of the pro-apoptotic Bcl-2 homology domain-3-only protein BMF.
Kilbride SM; Farrelly AM; Bonner C; Ward MW; Nyhan KC; Concannon CG; Wollheim CB; Byrne MM; Prehn JH
J Biol Chem; 2010 Nov; 285(46):36199-206. PubMed ID: 20841353
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of protein kinase B/Akt-1 mediates INS-1 insulinoma cell apoptosis induced by dominant-negative suppression of hepatocyte nuclear factor-1alpha function.
Wobser H; Bonner C; Nolan JJ; Byrne MM; Prehn JH
Diabetologia; 2006 Mar; 49(3):519-26. PubMed ID: 16440211
[TBL] [Abstract][Full Text] [Related]
5. The human glucagon-like peptide-1 analogue liraglutide regulates pancreatic beta-cell proliferation and apoptosis via an AMPK/mTOR/P70S6K signaling pathway.
Miao XY; Gu ZY; Liu P; Hu Y; Li L; Gong YP; Shu H; Liu Y; Li CL
Peptides; 2013 Jan; 39():71-9. PubMed ID: 23116613
[TBL] [Abstract][Full Text] [Related]
6. INS-1 cells undergoing caspase-dependent apoptosis enhance the regenerative capacity of neighboring cells.
Bonner C; Bacon S; Concannon CG; Rizvi SR; Baquié M; Farrelly AM; Kilbride SM; Dussmann H; Ward MW; Boulanger CM; Wollheim CB; Graf R; Byrne MM; Prehn JH
Diabetes; 2010 Nov; 59(11):2799-808. PubMed ID: 20682686
[TBL] [Abstract][Full Text] [Related]
7. Belinostat-induced apoptosis and growth inhibition in pancreatic cancer cells involve activation of TAK1-AMPK signaling axis.
Wang B; Wang XB; Chen LY; Huang L; Dong RZ
Biochem Biophys Res Commun; 2013 Jul; 437(1):1-6. PubMed ID: 23743198
[TBL] [Abstract][Full Text] [Related]
8. Akt activation protects pancreatic beta cells from AMPK-mediated death through stimulation of mTOR.
Cai Y; Wang Q; Ling Z; Pipeleers D; McDermott P; Pende M; Heimberg H; Van de Casteele M
Biochem Pharmacol; 2008 May; 75(10):1981-93. PubMed ID: 18377870
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of the ubiquitin-proteasome proteolysis system by amino acids and insulin involves the adenosine monophosphate-activated protein kinase and mammalian target of rapamycin pathways in rat hepatocytes.
Chotechuang N; Azzout-Marniche D; Bos C; Chaumontet C; Gaudichon C; Tomé D
Amino Acids; 2011 Jul; 41(2):457-68. PubMed ID: 20957397
[TBL] [Abstract][Full Text] [Related]
10. Interaction of glibenclamide and metformin at the level of translation in pancreatic β cells.
Wang Q; Cai Y; Van de Casteele M; Pipeleers D; Ling Z
J Endocrinol; 2011 Feb; 208(2):161-9. PubMed ID: 21084384
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide-1 analog-mediated protection against cholesterol-induced apoptosis via mammalian target of rapamycin activation in pancreatic βTC-6 cells -1mTORβTC-6.
Zhou J; Wu J; Zheng F; Jin M; Li H
J Diabetes; 2015 Mar; 7(2):231-9. PubMed ID: 24909811
[TBL] [Abstract][Full Text] [Related]
12. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity-onset diabetes of the young.
Ellard S; Colclough K
Hum Mutat; 2006 Sep; 27(9):854-69. PubMed ID: 16917892
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte nuclear factor 1A (HNF1A) as a possible tumor suppressor in pancreatic cancer.
Luo Z; Li Y; Wang H; Fleming J; Li M; Kang Y; Zhang R; Li D
PLoS One; 2015; 10(3):e0121082. PubMed ID: 25793983
[TBL] [Abstract][Full Text] [Related]
14. Leucine stimulates mammalian target of rapamycin signaling in C2C12 myoblasts in part through inhibition of adenosine monophosphate-activated protein kinase.
Du M; Shen QW; Zhu MJ; Ford SP
J Anim Sci; 2007 Apr; 85(4):919-27. PubMed ID: 17178807
[TBL] [Abstract][Full Text] [Related]
15. Isomers of the TCF1 gene encoding hepatocyte nuclear factor-1 alpha show differential expression in the pancreas and define the relationship between mutation position and clinical phenotype in monogenic diabetes.
Harries LW; Ellard S; Stride A; Morgan NG; Hattersley AT
Hum Mol Genet; 2006 Jul; 15(14):2216-24. PubMed ID: 16760222
[TBL] [Abstract][Full Text] [Related]
16. In vitro antiglioma action of indomethacin is mediated via AMP-activated protein kinase/mTOR complex 1 signalling pathway.
Pantovic A; Bosnjak M; Arsikin K; Kosic M; Mandic M; Ristic B; Tosic J; Grujicic D; Isakovic A; Micic N; Trajkovic V; Harhaji-Trajkovic L
Int J Biochem Cell Biol; 2017 Feb; 83():84-96. PubMed ID: 27988363
[TBL] [Abstract][Full Text] [Related]
17. 1, 25(OH)2D3 protects β cell against high glucose-induced apoptosis through mTOR suppressing.
Yang Z; Liu F; Qu H; Wang H; Xiao X; Deng H
Mol Cell Endocrinol; 2015 Oct; 414():111-9. PubMed ID: 26213322
[TBL] [Abstract][Full Text] [Related]
18. Involvement of mitochondrial dysfunction in human islet amyloid polypeptide-induced apoptosis in INS-1E pancreatic beta cells: An effect attenuated by phycocyanin.
Li XL; Chen T; Wong YS; Xu G; Fan RR; Zhao HL; Chan JC
Int J Biochem Cell Biol; 2011 Apr; 43(4):525-34. PubMed ID: 21163363
[TBL] [Abstract][Full Text] [Related]
19. Limitations in small intestinal neuroendocrine tumor therapy by mTor kinase inhibition reflect growth factor-mediated PI3K feedback loop activation via ERK1/2 and AKT.
Svejda B; Kidd M; Kazberouk A; Lawrence B; Pfragner R; Modlin IM
Cancer; 2011 Sep; 117(18):4141-54. PubMed ID: 21387274
[TBL] [Abstract][Full Text] [Related]
20. Rapamycin induces apoptosis of JN-DSRCT-1 cells by increasing the Bax : Bcl-xL ratio through concurrent mechanisms dependent and independent of its mTOR inhibitory activity.
Tirado OM; Mateo-Lozano S; Notario V
Oncogene; 2005 May; 24(20):3348-57. PubMed ID: 15782132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
